2-(3-bromophenyl)pyrimidine

Catalog No. :
ACQGZW492
CAS No. :
885468-36-0
Molecular Formula :
C10H7BrN2
Molecular Weight :
233.98

IUPAC Name:2-(3-bromophenyl)pyrimidine

2-(3-bromophenyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$118.00Login to see priceIn stockInquiry
250mg95%$257.00Login to see priceIn stockInquiry
1g95%$616.00Login to see priceIn stockInquiry
5g95%$2464.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-bromophenyl)pyrimidine
IUPAC Name2-(3-bromophenyl)pyrimidine
MDL No.MFCD08056330
Molecular FormulaC10H7BrN2
Molecular Weight233.98
SMILESBrC1=CC=CC(C2=NC=CC=N2)=C1
InChI KeyCETLQDSNTJEASI-UHFFFAOYSA-N
Synonym3-(PYRIMIDIN-2-YL)BROMOBENZENE;2-(3-BROMOPHENYL)PYRIMIDINE;1-Bromo-3-(pyrimidin-2-yl)benzene, 2-(3-Bromophenyl)-1,3-diazine;2-(3-Bromophenyl)pyrimidine97%;Pyrimidine, 2-(3-bromophenyl)-;3-(PYRIMIDIN-2-YL)BROMOBENZENE ISO 9001:2015 REACH
CAS No.885468-36-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Synthetic Route by SureRoute

1. ACQGZW492 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  2. Plus
  3. ACOGPU640 route compound structure diagram
    ACOGPU64089598-96-9 In Stock
  4. Then
  5. ACQGZW492 route product structure diagram
    ACQGZW492885468-36-0 In Stock
Inquiry

2. ACQGZW492 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOGPU640 route compound structure diagram
    ACOGPU64089598-96-9 In Stock
  4. Then
  5. ACQGZW492 route product structure diagram
    ACQGZW492885468-36-0 In Stock
Inquiry

Comments (0)